Dachaigh › Lymphoma Sòn Oir
Sgrùdaidhean clionaigeach Lymphoma Sòn Oir a’ fastadh anns na SA
Tha 56 sgrùdaidhean airson Lymphoma Sòn Oir a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- Durham, NC12 sgrùdaidhean
- New York City, NY11 sgrùdadh
- Seattle, WA9 sgrùdaidhean
- Milwaukee, WI9 sgrùdaidhean
- Boston, MA9 sgrùdaidhean
- Baldwin Park, CA9 sgrùdaidhean
- Rochester, MN8 sgrùdaidhean
- Edison, NJ8 sgrùdaidhean
- Columbus, OH8 sgrùdaidhean
- Houston, TX8 sgrùdaidhean
- Miami, FL7 sgrùdaidhean
- Nashville, TN7 sgrùdaidhean
- Denver, CO7 sgrùdaidhean
- Jacksonville, FL6 sgrùdaidhean
- St. Louis, MO6 sgrùdaidhean
- Salt Lake City, UT6 sgrùdaidhean
- Portland, OR5 sgrùdaidhean
- Queens, NY5 sgrùdaidhean
- Greenburgh, NY5 sgrùdaidhean
- Dallas, TX5 sgrùdaidhean
- Chicago, IL5 sgrùdaidhean
- Washington, DC5 sgrùdaidhean
- Atlanta, GA5 sgrùdaidhean
- Cleveland, OH5 sgrùdaidhean
- New Rochelle, NY4 sgrùdaidhean
- Minneapolis, MN4 sgrùdaidhean
- Staten Island, NY4 sgrùdaidhean
- Buffalo, NY4 sgrùdaidhean
- Los Angeles, CA4 sgrùdaidhean
- Tampa, FL4 sgrùdaidhean
- Cincinnati, OH4 sgrùdaidhean
- Philadelphia, PA4 sgrùdaidhean
- Ann Arbor, MI3 sgrùdaidhean
- Richmond, VA3 sgrùdaidhean
- East Norwalk, CT3 sgrùdaidhean
- Providence, RI3 sgrùdaidhean
- Mountain View, CA3 sgrùdaidhean
- Scottsdale, AZ3 sgrùdaidhean
- Cedar Rapids, IA3 sgrùdaidhean
- San Francisco, CA3 sgrùdaidhean
Le stàit
- Arizona5 sgrùdaidhean
- California18 sgrùdaidhean
- Colorado8 sgrùdaidhean
- Connecticut4 sgrùdaidhean
- Florida15 sgrùdaidhean
- Georgia6 sgrùdaidhean
- Illinois6 sgrùdaidhean
- Iowa4 sgrùdaidhean
- Kansas3 sgrùdaidhean
- Maryland6 sgrùdaidhean
- Massachusetts12 sgrùdaidhean
- Michigan5 sgrùdaidhean
- Minnesota12 sgrùdaidhean
- Missouri6 sgrùdaidhean
- New Jersey9 sgrùdaidhean
- New York16 sgrùdaidhean
- North Carolina14 sgrùdaidhean
- Ohio13 sgrùdaidhean
- Oregon5 sgrùdaidhean
- Pennsylvania5 sgrùdaidhean
- Rhode Island3 sgrùdaidhean
- Tennessee8 sgrùdaidhean
- Texas12 sgrùdaidhean
- Utah6 sgrùdaidhean
- Virginia4 sgrùdaidhean
- Washington10 sgrùdaidhean
- Wisconsin10 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
Intrathecal Cytarabine and Hydrocortisone for the Early Treatment of ICANS in Patients Undergoing CAR T Therapy for Non Hodgkin Lymphoma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT07763210A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07231952Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone Lymphoma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT07583810A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT05006716Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 110 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT00923507Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT06350318Epco, Zanu, Ritux for R/R FL or MZL
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06563596Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT04840602A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07101328Open-label of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Marginal Zone Lymphoma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT05296070Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT07225439A Study of ARC-02 in B-cell NHL
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 26 Lùna 2026 · NCT07691606Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone Lymphoma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Lùna 2026 · NCT04792502A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Lùna 2026 · NCT06149286AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 12 Lùna 2026 · NCT06340737HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 12 Lùna 2026 · NCT06792825Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
A’ fastadhÌre 1/2
Aoisean 13 gu 90 · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT06533579LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
A’ fastadhÌre 1
Aoisean 18 gu 81 · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT05990465A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 31 Iuch 2026 · NCT06708897A Study of APG-3288 in Relapsed/Refractory Blood Cancers
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Iuch 2026 · NCT07424833This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Iuch 2026 · NCT07121946Allo HSCT Using RIC and PTCy for Hematological Diseases
A’ fastadhÌre 2
Suas gu aois 75 · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT05805605A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Iuch 2026 · NCT05131022Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Iuch 2026 · NCT06860880Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Ògmh 2026 · NCT06905509Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.